Abstracts tagged "MRI and myositis"

Abstract Number: 291 • 2015 ACR/ARHP Annual Meeting
Correlations Between Muscle-MRI, Muscle Strength and Creatine Kinase Levels in the Anti-Synthetase Syndrome; A Comparative, Cross-Sectional Study
Helena Andersson¹, Eva Kirkhus², Else Merckoll², Ragnhild Walle-Hansen³ and Øyvind Molberg¹, ¹Department of Rheumatology, Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway, ²Department of Radiology, Oslo University Hospital, Oslo, Norway, ³Department of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway
Background/Purpose: Muscle MRI is used to describe the myositis component of the anti-synthetase syndrome (ASS), but the value of the examination is limited by lack…
Abstract Number: 2228 • 2014 ACR/ARHP Annual Meeting
Has MRI an Added Value over Serum Creatine Kinase Measurement in Myositis?
Nicolo Pipitone¹, Antonella Notarnicola², Giulio Zuccoli³, Lucia Spaggiari⁴, Gabriele Levrini⁵, Arnaldo Scardapane⁶, Florenzo Iannone², Giovanni Lapadula² and Carlo Salvarani¹, ¹Rheumatology Unit, Arcispedale S Maria Nuova, Reggio Emilia, Italy, ²D.I.M.I.M.P, Rheumatology Unit - University of Bari, Bari, Italy, ³Children's Hospital of Pittsburgh, Pittsburgh, PA, ⁴Radiology, Arcispedale S Maria Nuova, Reggio Emilia, Italy, ⁵Arcispedale S Maria Nuova, Reggio Emilia, Italy, ⁶Radiology, University of Bari, Bari, Italy
Background/Purpose MRI is widely used to assess inflammation in myositis. Muscle edema on short tau inversion recovery (STIR) sequences is thought to reflect active inflammation.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].